Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

TR-1: Notification of major holdings
TR-1: Notification of major holdings
TR-1: Notification of major holdings
eqs_en 
0 04.05.22
Unaudited NAV and Notice of Financial Results
Unaudited NAV and Notice of Financial Results
Unaudited NAV and Notice of Financial Results
eqs_en 
0 29.04.22
Hardman & Co Research: City of London Investment Group (CLIG) Fighting the market invasion
Hardman & Co Research: City of London Investment Group (CLIG) Fighting the market invasion
Hardman & Co Research: City of London Investment Group (CLIG) Fighting the market invasion
eqs_en 
0 28.04.22
Hardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
Hardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
Hardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
eqs_en 
0 19.04.22
Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-Thalassemia
Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-Thalassemia
Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-Thalassemia
eqs_en 
0 05.04.22
Hardman & Co Research: Oakley Capital Investments Ltd (OCI) - Proving the pudding: a sustainable growth model
Hardman & Co Research: Oakley Capital Investments Ltd (OCI) - Proving the pudding: a sustainable growth model
Hardman & Co Research: Oakley Capital Investments Ltd (OCI) - Proving the pudding: a sustainable growth model
eqs_en 
0 16.03.22
Corporate update from portfolio company Harpoon Therapeutics
Corporate update from portfolio company Harpoon Therapeutics
Corporate update from portfolio company Harpoon Therapeutics
eqs_en 
0 14.03.22
Form 8.3 - The Vanguard Group, Inc.: McKay Securities plc
Form 8.3 - The Vanguard Group, Inc.: McKay Securities plc
Form 8.3 - The Vanguard Group, Inc.: McKay Securities plc
eqs_en 
0 03.03.22
Edison Investment Research Limited: Primary Health Properties (PHP): Continuing strong DPS growth well supported
Edison Investment Research Limited: Primary Health Properties (PHP): Continuing strong DPS growth well supported
Edison Investment Research Limited: Primary Health Properties (PHP): Continuing strong DPS growth well supported
eqs_en 
0 02.03.22
Hardman & Co Research: City of London Investment Group (CLIG) Confirming an excellent first half
Hardman & Co Research: City of London Investment Group (CLIG) Confirming an excellent first half
Hardman & Co Research: City of London Investment Group (CLIG) Confirming an excellent first half
eqs_en 
0 23.02.22
Hardman & Co Research: Oakley Capital Investments (OCI) Educating on education
Hardman & Co Research: Oakley Capital Investments (OCI) Educating on education
Hardman & Co Research: Oakley Capital Investments (OCI) Educating on education
eqs_en 
0 09.02.22
Total Voting Rights
Total Voting Rights
Total Voting Rights
eqs_en 
0 08.02.22
Arix Bioscience PLC: Clinical development update from portfolio company LogicBio
Arix Bioscience PLC: Clinical development update from portfolio company LogicBio
Arix Bioscience PLC: Clinical development update from portfolio company LogicBio
eqs_en 
0 02.02.22
Hardman & Co Research: CyanConnode (CYAN) - 3Q22 update: smart meter showtime in India
Hardman & Co Research: CyanConnode (CYAN) - 3Q22 update: smart meter showtime in India
Hardman & Co Research: CyanConnode (CYAN) - 3Q22 update: smart meter showtime in India
eqs_en 
0 01.02.22
Hardman & Co Research: City of London Investment Group (CLIG) - You're so special!
Hardman & Co Research: City of London Investment Group (CLIG) - You're so special!
Hardman & Co Research: City of London Investment Group (CLIG) - You're so special!
eqs_en 
0 20.01.22
Notification of Major Share Holding
Notification of Major Share Holding
Notification of Major Share Holding
eqs_en 
0 11.01.22
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals
eqs_en 
0 22.12.21
Edison Investment Research Limited: Fidelity Emerging Markets (FEML): Initiation - Refocusing on higher returns
Edison Investment Research Limited: Fidelity Emerging Markets (FEML): Initiation - Refocusing on higher returns
Edison Investment Research Limited: Fidelity Emerging Markets (FEML): Initiation - Refocusing on higher returns
eqs_en 
0 20.12.21
Arix Bioscience PLC: Director/PDMR Shareholdings
Arix Bioscience PLC: Director/PDMR Shareholdings
Arix Bioscience PLC: Director/PDMR Shareholdings
eqs_en 
0 17.12.21
Hardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!
Hardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!
Hardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!
eqs_en 
0 16.12.21
Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing
Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing
Arix Bioscience PLC: Depixus raises €30.6M (£26.1 million) in Series A Financing
eqs_en 
0 15.12.21
Arix Bioscience PLC: Imara Presents Clinical and Preclinical Tovinontrine (IMR-687) Data at the American Society of Hematology (ASH) Annual Meeting 2021
Arix Bioscience PLC: Imara Presents Clinical and Preclinical Tovinontrine (IMR-687) Data at the American Society of Hematology (ASH) Annual Meeting 2021
Arix Bioscience PLC: Imara Presents Clinical and Preclinical Tovinontrine (IMR-687) Data at the American Society of Hematology (ASH) Annual Meeting 2021
eqs_en 
0 13.12.21
Arix Bioscience PLC: Autolus Therapeutics presents positive obe-cel data at the American Society of Hematology (ASH) Annual Meeting 2021
Arix Bioscience PLC: Autolus Therapeutics presents positive obe-cel data at the American Society of Hematology (ASH) Annual Meeting 2021
Arix Bioscience PLC: Autolus Therapeutics presents positive obe-cel data at the American Society of Hematology (ASH) Annual Meeting 2021
eqs_en 
0 13.12.21
Hardman Talks | Oakley Capital Investments Webinar: Everything you wanted to know about private equity but were afraid to ask!
Hardman Talks | Oakley Capital Investments Webinar: Everything you wanted to know about private equity but were afraid to ask!
Hardman Talks | Oakley Capital Investments Webinar: Everything you wanted to know about private equity but were afraid to ask!
eqs_en 
0 02.12.21
Hardman & Co: Hardman Talks Video Event | Oakley Capital Investments Live Q&A Webinar
Hardman & Co: Hardman Talks Video Event | Oakley Capital Investments Live Q&A Webinar
Hardman & Co: Hardman Talks Video Event | Oakley Capital Investments Live Q&A Webinar
eqs_en 
0 01.12.21